Trexquant Investment’s Merck MRK Stock Holding History

Trexquant Investment’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$144K	Buy	+1,200	New	+$139K	﹤0.01%	1686

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Trexquant Investment's MRK Position: Q3 2025 in Review

Trexquant Investment sold out of Merck (MRK) in Q3 2025, closing a stake of 196,112 shares — an estimated $15.5M sold.

Trexquant Investment first reported a position in MRK in Q4 2014 and held it in 24 quarters. The position peaked at $37.3M in Q1 2025. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

Trexquant Investment reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
Trexquant Investment sold 196,112 Merck shares in Q3 2025, an estimated $15.5M.
Trexquant Investment first reported a position in Merck in Q4 2014 and held it in 24 quarters.
Trexquant Investment's Merck position peaked at $37.3M in Q1 2025.
3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Trexquant Investment's 13F filing for Q3 2025, filed 14 Nov 2025.